The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy

ConclusionsOur data suggest that lixisenatide has a protective effect on the diabetic retina, most likely due to a combination of neuroprotective, anti-inflammatory and antioxidative effects of lixisenatide on the neurovascular unit.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research